Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy
- 1 October 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (10) , 1226-1230
- https://doi.org/10.1016/0277-5379(91)90086-s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Assessing the effect of toxicity on prognosis: methods of analysis and interpretation.Journal of Clinical Oncology, 1988
- A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver MetastasesAnnals of Surgery, 1987
- Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primariesCancer, 1986
- Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma.Journal of Clinical Oncology, 1984
- Regional chemotherapy of colorectal cancer metastatic to the liverCancer, 1984
- Analysis of survival by tumor response.Journal of Clinical Oncology, 1983
- A Prospective Phase II Clinical Trial of Continuous FUDR Regional Chemotherapy for Colorectal Metastases to the LiverAnnals of Surgery, 1983
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Evaluation of hepatic dearterialization in primary and secondary cancer of the liverThe American Journal of Surgery, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958